Alternative genetic alterations of MYC, BCL2, and/or BCL6 in high‐grade B‐cell lymphoma (HGBL) and diffuse large B‐cell lymphoma (DLBCL): Can we identify different prognostic subgroups?

The International Consensus Classification of Mature Lymphoid Neoplasms: A Report from the Clinical Advisory Committee

(2022) Elias Campo et al.   BLOOD

Bright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High Specificity

(2019) Abdullah Alsuwaidan et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Lymphomas with pseudo-double hit BCL6 - MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations

(2018) Steven M. Johnson et al.   HUMAN PATHOLOGY

Double hit and double expressors in lymphoma: Definition and treatment

(2018) Peter A. Riedell et al.   CANCER

Expression Profiles of MYC Protein and MYC Gene Rearrangement in Lymphomas

(2015) Karen M. Chisholm et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma

(2015) Daniel J. Landsburg et al.   CANCER

Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma

(2015) R. J. H. Ryan et al.   Cancer Discovery

MYC-associated and double-hit lymphomas: A review of pathobiology, prognosis, and therapeutic approaches

(2014) Adam M. Petrich et al.   CANCER

B-cell lymphomas with concurrent MYC and BCL2 abnormalities other than translocations behave similarly to MYC/BCL2 double-hit lymphomas

(2014) Shaoying Li et al.   MODERN PATHOLOGY

Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC

(2014) S. H. Swerdlow   Hematology-American Society of Hematology Education Program